title: Recommendations for the registration of drugs intended for use in the treatment of male osteoporosis.
authors.affiliation: Universitair Ziekenhuis Gent, Ghent, Belgium.
authors.forename: J M
authors.initials: JM
authors.lastname: Kaufman
authors.forename: J
authors.initials: J
authors.lastname: Compston
authors.forename: M A
authors.initials: MA
authors.lastname: Audran
authors.forename: B
authors.initials: B
authors.lastname: Avouac
authors.forename: J P
authors.initials: JP
authors.lastname: Devogelaer
authors.forename: E M
authors.initials: EM
authors.lastname: Lemmel
authors.forename: L
authors.initials: L
authors.lastname: Vanhaelst
authors.forename: J Y
authors.initials: JY
authors.lastname: Reginster
mesh_terms: D000818:Animals; D002979:Climacteric; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D015507:Drugs, Investigational / Q000627:therapeutic use; D005060:Europe; D006291:Health Policy; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy*; D004364:Pharmaceutical Preparations / Q000592:standards*; D012042:Registries
chemical_list: D015507:Drugs, Investigational; D004364:Pharmaceutical Preparations